References
- Finseth F, Adelberg MG. Prevention of skin flap necrosis by a course of treatment with vasodilator drugs. Plast Reconstr Surg. 1978;61:738–743.
- Yang RZ, Lee MJ, Hu H, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol-Endocrinol Metab. 2006;290:E1253–E1261.
- Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907–917.
- Yamawaki H, Tsubaki N, Mukohda M, et al. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun. 2010;393:668–672.
- Yamawaki H. Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses. Biol Pharm Bull. 2011;34:307–310.
- McFarlane RM, Deyoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg. 1965;35:177–182.
- Khouri RK, Angel MF, Edstrom LE. Standardizing the dorsal rat flap. Surg Forum. 1986;37:590–591.
- Aarts HF. Regional intravascular sympathetic blockade for better results in flap surgery: an experimental study of free flaps, island flaps, and pedicle flaps in the rabbit ear. Plast Reconstr Surg. 1980;66:690–698.
- Adanalı G, Seyhan T, Turegun M, et al. Effects of different vascular patterns and the delay phenomenon on rat ventral island flap viability. Ann Plast Surg. 2002;48:660–664.
- Erdem I. Kranial pediküllü dorsal rat flebinde mikronize flavonoid fraksiyonunun distal flep nekrozuna etkisi. T. C. Dicle Üniversitesi Tıp Fakültesi Plastik ve Rekonstrüktif Cerrahi AD Uzmanlık tezi. Diyarbakır; 1998.
- Kargi E, Deren O, Babuccu O, et al. Dual synergistic effect: the effect of dexamethasone plus carnitine on skin flap survival. Ann Plast Surg. 2004;53:488–491.
- Hosnuter M, Babuccu O, Kargi E, et al. Dual preconditioning: effects of pharmacological plus ischemic preconditioning on skin flap survival. Ann Plast Surg. 2003;50:398–402.
- Kim WS, Park BS, Sung JH, et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007;48:15–24.
- Batista C, Yang RZ, Lee MJ, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56:1655–1661.
- Knox LK, Stewart AG, Hayward PG, et al. Nitric oxide synthase inhibitors improve skin flap survival in the rat. Microsurgery. 1994;15:708–711.
- Wise LM, Inder MK, Real NC, et al. The vascular endothelial growth factor (VEGF)-E encoded by orf virus regulates keratinocyte proliferation and migration and promotes epidermal regeneration. Cell Microbiol. 2012;14:1376–1390.
- Viac J, Palacio S, Schmitt D, et al. Expression of vascular endothelial growth factor in normal epidermis epithelial tumors and cultured keratinocytes. Arch Dermatol Res. 1997;289:158–163.
- Khan A, Ashrafpour H, Huang N, et al. Acute local subcutaneous VEGF165 injection for augmentation of skin flap viability: efficacy and Mechanism. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1219–R1229.
- Zhong X, Li X, Liu F, et al. Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway. Biochem Biophys Res Commun. 2012;425:401–406.
- Zhaoxia W, Tomohiro N. Inflammation a link between obesity and cardiovascular disease. Mediators Inflamm. 2010; 2010:535918.
- Senolt L, Polanska M, Filkova M, et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis. 2010;69:1410–1411.
- Tan BK, Adya R, Farhatullah S, et al. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes. 2010;59:3023–3031.
- Xia Z, Hai-Yang Z, Hui T, et al. , Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin. 2011;32:873–887.
- Angel MF, Narayanan K, Swartz WM, et al. Deferoxamine increases skin flap survival: additional evidence of free radical involvement in ischaemic flap surgery. Br J Plast Surg. 1986;39:469–472.
- Zhang F, Oswald T, Lin S, et al. Vascular endothelial growth factor (VEGF) expression and the effect of exogenous VEGF on survival of a random flap in the rat. Br J Plast Surg. 2003;56: 653–659.
- Hsu C, Chang J. Clinical implications of growth factors in flexor tendon wound healing. J Hand Surg Am. 2004;29:551–563.
- Zacchigna S, Papa G, Antonini A, et al. İmproved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno associated virus vectors. Am J Pathol. 2005;167:981–991.
- Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435–439.
- Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439–442.
- Fukumura D, Gohongi T, Kadambi A, et al. Predominantrole of endothelial nitricoxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA. 2001;98:2604–2609.
- Lee C, Kerrigan CL, Picard-Ami LA Jr. Cyclophosphamide-induced neutropenia: effect on postischemic skin-flap survival. Plast Reconstr Surg. 1992;89:1092–1097.
- Mittermayr R, Valentini D, Fitzal F, et al. Protective effect of a novel NO-donor on ischemia/ reperfusion injury in a rat epigastric flap model. Wound Repair Regen. 2003;11:3–10.
- Khiabani KT, Kerrigan CL. Presence and activity of nitric oxide synthase isoforms in ischemia–reperfusion-injured flaps. Plast Reconstr Surg. 2002;109:1638–1645.